Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-adenosylmethionine for depression in Lesch-Nyhan syndrome
2007-004036-23Phase 4Completed
- Sponsor
- Fondazione Malattie Rare Mauro Baschirotto B.I.R.D. Onlus
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of S-adenosylmethionine in major depressive disorder (MDD) and Lesch-Nyhan syndrome (LNS), sponsored by Fondazione Malattie Rare Mauro Baschirotto B.I.R.D. Onlus. Primary endpoint: Mood improvement with reduction of Lesch-Nyhan behaviours. Started Jul 2010; status: completed.
02
Drugs
S-adenosylmethionine
03
Conditions
major depressive disorder (MDD)Lesch-Nyhan syndrome (LNS)
Beyond the preview
Go deeper on 2007-004036-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004036-23.